Earnings Labs

Barings BDC, Inc. (BBDC)

Q4 2022 Earnings Call· Fri, Feb 24, 2023

$8.98

+1.81%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+0.12%

1 Week

-0.35%

1 Month

-10.88%

vs S&P

-14.11%

Transcript

Operator

Operator

At this time, I would like to welcome everyone to the Barings BDC, Inc. Conference Call for the Quarter and Year ended December 31, 2022. All participants are in a listen only mode. A question-and-answer session will follow the company’s formal remarks [Operator Instructions]. Today's call is being recorded, and a replay will be available approximately 2 hours after the conclusion of the call on the company's Web site at www.baringsbdc.com under the Investor Relations section. Please note that this call may contain forward-looking statements that include statements regarding the company's goals, beliefs, strategies, future operating results and cash flows. Although the company believes these statements are reasonable, actual results could differ materially from those projected in the forward-looking statements. These statements are based on various underlying assumptions and are subject to numerous uncertainties and risks, including those disclosed under the section titled Risk Factors and Forward-Looking Statements in the company's annual report on Form 10-K for the fiscal year ended December 31, 2022 as filed with the Securities and Exchange Commission. Barings BDC undertakes no obligation to update or revise any forward-looking statements unless required by law. At this time, I would like to turn the call over to Eric Lloyd, Chief Executive Officer of Barings BDC.

Eric Lloyd

Analyst

Thank you, operator. And good morning, everyone. We appreciate you joining us for today's call. Please note that throughout today's call, we'll be referring to our fourth quarter 2022 earnings presentation that is posted on the Investor Relations section of our Web site. On the call today, I'm joined by Barings Co-Head of Global Private Finance and President of Barings BDC, Ian Fowler; Barings Head of Capital Solutions and Co-Portfolio Manager, Bryan High; and the BDCs Chief Financial Officer, Jonathan Landsberg. As is customary, Ian, Bryan and Jonathan will review details of our portfolio and fourth quarter results in a moment, but I'll start off with some high level comments about the quarter. Let's begin with the market backdrop shown on Slide 5 of the presentation. In a market characterized by significant concerns around inflation, economic growth and geopolitical risks and one in which the unprecedented pace of global interest rate hikes elevates volatility in both leveraged loans and BDC equities, Barings BDC continued to generate strong economic results. Turning to the fourth quarter highlights on Slide 6. Net asset value per share was $11.05 compared to the prior quarter of $11.28, down by 2%. We had one new non-accrual in the quarter, Core Scientific, which we discussed on our last call in November and on our unrealized write-down of the asset contributed $0.17 of NAV reduction. Outside of Core Scientific, the reduction in our NAV was driven primarily by unrealized write-downs tied to macroeconomic factors and spread widening as opposed to fundamental credit related factors in our portfolio. Our net investment income was $0.34 per share compared to $0.26 per share last quarter, an increase of 33% quarter-over-quarter as our portfolio benefited substantially from the rise in base rates. In addition, Barings earned no incentive income incentive fee in…

Ian Fowler

Analyst

Thanks, Eric, and good morning, everyone. If you turn to Slide 9, you can see additional details on the investment activity mentioned previously. Our middle market portfolio increased by $184 million on a net basis in the quarter with gross fundings of $205 million, offset by repayments of $21 million. It is not surprising that repayment activity has slowed in this environment. As the market adjusts to the realities of higher interest rates and what that implies for company valuations and supportable capital structures. That said, new middle market investments included 21 new platform investments totaling $167 million and $39 million of follow-on investments in delayed draw term loan fundings as we continue to deploy capital at a very attractive risk return profiles in partnership with longstanding sponsors. Our cross-platform portfolio decreased by $26 million on a net basis in the quarter with $35 million of new originations versus $61 million of repayments. We continue to remain active with realizations and sales at both MVC and Sierra, and this quarter generated $30 million of liquidity via sales, paydowns and prepayments. Slide 10 updates the data we show you each quarter on middle market spreads across the capital structure and clearly, investment spreads across public and private asset classes have widened. Most important, public market spreads continued to exceed those of private middle market loans. While it looks like the illiquidity premium or the extra spread to take a deal private to loan investors remains much smaller than in the past, there have been stretches where the liquid loan market has been effectively shut to new issuers, meaning the relative attractiveness of the direct lending solution in today's marketplace for private equity sponsors is very high. A bridge of our investment portfolio from September 30th to December 31st, is shown on…

Jonathan Landsberg

Analyst

Thanks, Ian. Turning to Slide 16. Here is the full bridge of the NAV per share movement in the fourth quarter. Our net investment income exceeded our dividend by $0.10 per share. Share repurchases added another $0.02 per share and combined net realized gains and unrealized depreciation reduced NAV by $0.35 per share. Additional details on the net unrealized depreciation are shown on Slide 17. Of the total $56 million in unrealized depreciation in the fourth quarter, approximately $21 million was due to price or spread moves while $26 million were due to credit factors. The cross-platform portfolio contributed $9 million of the total price driven depreciation, primarily tied to the more liquid investments, such as situational BSLs or underlying investments in our joint ventures, while the majority of the credit related write down was due to Core Scientific. Notably, the legacy MVC portfolio saw total depreciation of $9 million tied to underlying credit performance while the Sierra portfolio had total depreciation of $8 million, $5 million of which was due to price movements predominantly tied to the Sierra JV. Near the bottom of Slide 18, you can see that the credit support agreements increased approximately $4 million as a result of investment marks. Slides 18 and 19 show our income statement and balance sheet for the last five quarters. Our net investment income per share was $0.34 for the quarter, driven by an 18% quarter-over-quarter increase in total interest income and the elimination of the incentive fee because of our total return hurdle. From a balance sheet perspective on Slide 19, total debt to equity was 1.22 times at December 31s. Although, as is typical, this level was elevated due to high quarter end cash balances. Our net leverage ratio was 1.12 times and we view this measure as…

Operator

Operator

[Operator Instructions] Our first question today is from Kyle Joseph of Jefferies.

Kyle Joseph

Analyst

Congrats on a strong quarter. Ian, I just want to pick your brain on kind of that supply demand dynamics in the market. Obviously, from your comments, I got the sense that supply is constrained more on the liquid side. So the more borrowers are relying on the direct lending path. But in terms of demand, it seems relatively resilient in my mind, particularly when you look at what the Fed has done and how it's impacted other sort of fixed income instruments, mortgage. So just talk about kind of how or why the origination environment has been as strong as it has been for you guys in the face of 500 basis points of Fed hikes?

Ian Fowler

Analyst

There's a couple of things I want to cover on that. First of all, just given the liquid market and the shutdown of the liquid market, I mean that really started happening last year, obviously. And as we look at last year, I think as we evolve further in the year, some of these geopolitical and macroeconomic issues became more significant, especially with the rapid rise in hikes by the Fed. And so I think before that really started to take hold, I think as the liquid market was shutting down and having difficulty, it was an opportunity for direct lenders to basically move up market and take market share from a dislocated liquid market. I think as the year progressed and some of these economic challenges became bigger or more significant headwinds, I think the capital that was moving into that segment of the market started to pull back. And quite frankly, when you think about that part of the market segment, the larger part of that market, in the past, what's been attractive for direct lenders in that space is the ability to recycle and recycle capital, and that's a great return profile. But obviously, with the liquid market being shut down, there's no recycling of that capital. So they're really holding these big chunky positions. For us, focus on the middle of the middle market, a lot of our activity is coming from our portfolio, which is really attractive. It basically allows us to in a challenging environment to put capital to work in companies we know extremely well. The add-on acquisitions are effectively making these companies bigger, stronger, more diversified credits, which enhances our portfolio. And in an environment where I think a lot of private equity firms are concerned about valuations and what they paid for the initial platform, the ability to play the multiple arbitrage game and do add-on acquisitions at a lower cost basis effectively brings down their cost basis of the original investment. So it's kind of a win-win situation. I would say in the last year, about 50% of our origination is coming from our portfolio.

Operator

Operator

Our next question is from Casey Alexander of Compass Point.

Casey Alexander

Analyst

Ian, I don't -- perhaps I'm not bright enough. I'm not even sure that maybe you didn't just answer my question, but I'm going to ask it anyway. A clear defined strategy of Barings BDC when it originally came out was when the risk premium from the private debt markets was not a sufficient premium relative to the liquid traded markets that the BDC had the opportunity to pivot, and as opposed to making private loans, allocate more capital to the liquid markets at a discount to par, which could then be recycled out to private loans when the risk premium for private loans increased. And I'm curious, given this particular risk premium, why the company isn't taking more advantage of that opportunity.

Ian Fowler

Analyst

Well, I mean, look, I'll let Eric jump into from a high level. But I mean, again, I think if you kind of look at what's going on in the markets, right? I mean, the opportunity to take advantage -- and things are changing. I think right now, you're seeing some high quality deals in the liquid market -- come to the market at attractive levels. But I mean, again, if you kind of look at what's happened over the last year, with the liquid market shut down, it's just -- there's just no good new issues that are coming to the market. And when you think about the…

Casey Alexander

Analyst

This isn't a question about new issues. This is a question about liquid traded paper that you guys know that trades out in the market at a discount to par. This has nothing to do with new issue…

Ian Fowler

Analyst

No. I understand, Casey. I'm just saying, and I'm getting there. I'm just saying that when I'm focused obviously on the middle market, Barings has beautiful portfolio. And so when we look at that portfolio and we can generate with good issues, we can generate senior debt at 5 times at 10% to 11% in yield, that's pretty attractive.

Eric Lloyd

Analyst

I'd look at it this way. We evaluate it all the time. And one of the things that Bryan High, who’s one of our co-portfolio managers on here, too, and passed it then on the liquid investment committee, and we are plugged into that business very tightly. But when we look at it, we just don't think it's the right time on a relative basis of that asset relative to what we could get on the private side. As Ian said, you can put 5 turns of leverage on something, earn 10% to 11% with the best documentation we've seen in years -- many, many years and we compare that to what we saw on the liquid side on a secondary basis, we looked at that and said it wasn't the right time to go into the secondary part of the liquid market relative to what we can generate through our cross-platform and direct middle market business.

Casey Alexander

Analyst

My second question is conditions underlying Core Scientific and the Core Scientific loan have changed since you guys had to make that mark at the end of the fourth quarter. Can you contour to a certain extent where your discussions are with Core Scientific and how you perhaps see that playing out now that you have some more price discovery for crypto here in the first quarter and maybe a little differentiated view towards the outlook?

Bryan High

Analyst

Just in terms of giving too much detail, there's not a lot we can share. Obviously, we're engaged in the situation, we're partnered with MassMutual and our meaningful equipment loan holder across the platform. But in terms -- yes, the price of bitcoin, which helps buoy the business from a cash generation perspective, has increased 50%, and that’s kind of seem to have stabilize at the moment at higher levels. In terms of the engagement, I mean, obviously, it's public, everything is out there. They've changed the dip lender. I think it's going to take some time to work through the process, and we're playing our part in that process.

Operator

Operator

The next question is from Robert Dodd of Raymond James.

Robert Dodd

Analyst

Ian, on the names you said, there are 17 names on the watch list, 2.6%]. You said no particular theme. But any of those names -- any of those on that solely because interest is higher? And separate related question, are any of those names non-sponsored? And what are the extra steps you take in -- not in underwriting, but monitoring and discussion with the portfolio company when there isn’t a sponsor there given maybe in the high rate environment, more capital injections either and there's no sponsor, who's going to do it?

Ian Fowler

Analyst

So first of all, just to clarify that we call it focus and watch list. So it incorporates watch list, I think we all understand what a watch list is. Focus means the company is -- their performance is not tracking to what we underwrote in what we thought. It doesn't necessarily mean it's extremely bad. In some cases, it could be the company is generating performance that can be positive and it's trying to -- we're trying to figure out what's driving the change, the delta from how we underwrote it. So I want to be clear on that. Second of all, all the deals on this list are sponsored back. I think our focus, again, going back to the Barings is beautiful, is there's just so many reasons to focus on sponsored deals, more information going in. To your point, you have more levers to pull when you have issues. And most importantly, you're not the only source of capital. And I think the deals are the most challenging, quite frankly, are the ones where the management team owns the company because, effectively, they have all the leverage in the world, they can just go across the street and open up another shop. And so I think as as a business and as a portfolio manager, the key in this market, as I referenced, is being really proactive with these companies and these management teams. Because what you really want to do is you want to identify issues early on, you want to identify trajectories that are not in line with expectations and start working and communicating with the interested parties, the management team and the sponsor to figure out how we're going to get this company back on track. And so when we're -- we've done a…

Robert Dodd

Analyst

I really appreciate all that color. And it's not really about interest coverage, I’s about tails, but we've got an average interest coverage metric on Slide 12, 2.9 times I presume that's the LTM. Where do you think -- where would that have to go for you to really feel stressed about a broader part of the portfolio, right? I mean, obviously, it's an average and the average is never the problem. But is there anything we can look at on that 2.9 times? I mean how far into comfortable range is that currently, and how much does it have to move before you’re actually stressed.

Ian Fowler

Analyst

And again, I think this is the time where you have to prepare for the worst and hope for the best. None of us have a crystal ball. And so we've taken base rates when we've done our stress test, we've taken place up to 5.5%. And we're just -- we're right around 2 times coverage, just under 2 times coverage. But you have to recall, right, or you have to remember that, that is just taking the existing LTM performance and of the companies, and putting in elevated interest rates, obviously, our goal here is to work with these companies. And hopefully, they're doing things on their end to cut costs. Hopefully, they continue to put through price increases. So when we do these stress tests, we're really assuming that none of these companies are doing anything to address the challenges out there. And I guess the other thing I'll point out is that well, unfortunately, we used to have it in our documents, which was taken out over the last five years, but we used to force sponsors to fix 50% of their interest rate exposure, that's been taken out in the market. But I can tell you a lot of private equity firms that we're working with on a portfolio basis have incorporated swaps and hedges to minimize the floating rate risk.

Operator

Operator

The next question is from Ryan Lynch of KBW.

Ryan Lynch

Analyst

Just following up on Robert -- last question, when you talked about stressing the portfolio, charge interest rates go 5.5%, base rates with 2 times interest coverage. Have you guys done an analysis that looks at what percentage of the portfolio would be below 1 times interest coverage with 5.5% interest rates?

Ian Fowler

Analyst

Yes, we've done the -- yes, that was really the focus of the stress test, and it's a low single digit. And again, this is not on just the BDC. So we're talking about our entire platform, which the BDC is a representation of. And again, I just want to emphasize, when you do the stress test, you're again assuming these companies aren't doing anything on their side. And you're also assuming they're completely exposed and unhedged. So again, we feel very comfortable about where we are if rates go to base rates of 5.5%.

Ryan Lynch

Analyst

Another question I had was -- and we've talked about this. I've talked about this with you all in the past. But when I look at your portfolio, the segmentation on Slide number 12, you guys have talked about in the past kind of Barings has beautiful strategy overall. But when I look at that portfolio, to me, there's -- at least when you compare it to a traditional BDC segmentation, it's much more complex. And I know you guys think that there's some value in that complexity, in particular with some of the cross platform investments. I'm just curious, obviously, some of those segments are going to roll off of actually, particularly the acquisitions of Sierra and MVC. I'm just curious now that there's been some recent leadership changes at Barings, do you guys foresee your focus on sort of the segmentation of some of these different strategies of only right now having 46% in US middle market loans is quite a small percentage versus most other BDCs out there. Has there been any sort of strategy shift with the leadership changes of how you guys want to mold and prep this portfolio over the next couple of years?

Eric Lloyd

Analyst

I would say it’s much a strategy shift as much as a simplification around some things. Not all but some of the complexity in our portfolio is from the acquired portfolios that we put in place. I mean, now [indiscernible] that we acquired as part of the two transactions. We don't intend to do those type of deals going forward. And so as those roll off, I think you'll see some simplification within the portfolio. I also think that we will continue to look for opportunities where the core Barings capabilities can be brought to bear on behalf of shareholders. But I don't think you'll see it in some of the more complex ways that it was [indiscernible] [through] some of the acquired portfolios that we did.

Jonathan Landsberg

Analyst

The only thing I'll add is that you've seen maybe on some of the JVs, right, this year JV, we're returning capital, that vehicle is winding down. You've seen the same thing with Thompson Rivers as those loans were [pool], we've been actively returning capital as that trade has sort of run its course. So at the margin, yes, you'll see some vehicles that wind down going forward. But the view of finding relative value across the wide Barings frame of reference, no, we don't think that strategy changes.

Operator

Operator

There are no additional questions at this time. I'd like to turn the call back to Eric Lloyd for closing remarks.

Eric Lloyd

Analyst

Thank you. Thanks for everyone who participated today on today's call. I appreciate you taking the time to listen to us and ask your questions. Please stay-safe. And everybody, have a great day and weekend.

Operator

Operator

This concludes today's conference. You may disconnect your lines at this time. Thank you for your participation.